GERRI MARTIN: Open Payments
NPI 1346721271 · PIKEVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$656 in 40 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $241 · 2025 $656
Food & beverage: $656
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $244 |
| Amgen Inc. | 12 | $165 |
| Lilly USA, LLC | 4 | $66 |
| Phathom Pharmaceuticals, Inc. | 4 | $50 |
| VERTEX PHARMACEUTICALS INCORPORATED | 2 | $48 |
| AstraZeneca Pharmaceuticals LP | 2 | $32 |
| Novo Nordisk Inc | 1 | $18 |
| PFIZER INC. | 1 | $17 |
| Tonix Medicines, Inc. | 1 | $16 |
Products named: QULIPTA, OTEZLA, VRAYLAR, MOUNJARO, VOQUEZNA, JOURNAVX, BOTOX, VYNDAMAX.
Industry payments across KY — which companies pay providers there.
